Recently Updated
In an awe-inspiring live stream event, Neuralink, the neurotechnology company founded by visionary entrepreneur Elon Musk, demonstrated the remarkable capabilities of their groundbreaking N1 chip. The showcase featured a quadriplegic patient who, in a telepathy-like display, controlled a laptop cursor using only the power of his mind.
This incredible milestone comes after the successful implantation of the Neuralink chip in the first human test subject, a patient who had lost sensation in his shoulders following a severe accident eight years ago. The achievement is a testament to the relentless dedication and innovation of the Neuralink team, who received FDA approval for first-in-human trials last year.
Responding to the live stream, Elon Musk, ever the optimistic futurist, shared his long-term vision for the technology. He expressed that it may one day be possible to *shunt signals from the brain's motor cortex past the damaged part of the spine,* empowering paralyzed individuals to walk and use their arms again. This bold aspiration embodies Musk's commitment to pushing the boundaries of what is possible and transforming lives for the better.
Musk also revealed that the next Neuralink product, following the development of telepathy, will be focused on restoring sight to the blind, a concept known as *blindsight.* This announcement further demonstrates the company's ambition to harness cutting-edge technology to address some of humanity's most pressing challenges.
With unwavering determination, Neuralink aims to test their technology with more individuals who have lost sensation in parts of their bodies due to accidents or birth conditions. Ultimately, the company envisions making the Neuralink chip available to everyone, potentially revolutionizing the way humans interact with technology and each other. As Elon Musk and Neuralink continue to redefine the limits of human potential, the future looks brighter than ever.
Neuralink, the neurotechnology company founded by Elon Musk, made headlines yesterday with a live stream showcasing the capabilities of their N1 chip. The demonstration featured a quadriplegic patient who was able to control a laptop cursor using only his mind, exhibiting a telepathy-like ability.
First Human Test Subject Successfully Implanted with Neuralink Chip
The patient, who lost sensation in his shoulders after a severe accident eight years ago, became one of the first human test subjects to receive the Neuralink chip. This significant milestone comes after the company received #FDA approval last year for first-in-human trials.
— Neuralink (@neuralink) March 20, 2024
Elon Musk’s Vision for Neuralink
Responding to the #live stream, Elon Musk expressed his long-term vision for the technology. He stated that it may eventually be possible to shunt signals from the brain’s motor cortex past the damaged part of the spine, enabling paralyzed individuals to walk and use their arms again.
Blindsight is the next @Neuralink product after Telepathy
— Elon Musk (@elonmusk) March 20, 2024
Blindsight: The Next Neuralink Product After #Telepathy
Musk also revealed that the next Neuralink product, following the development of telepathy, will be blindsight. This term refers to the ability of blind individuals to respond to visual stimuli without consciously seeing them. The company hopes to develop technology that can restore sight to those who have lost it.
Neuralink’s Ambition to Help People Regain Lost Sensations
Neuralink aims to test their technology with more individuals who have lost sensation in parts of their bodies due to accidents or birth conditions. Ultimately, the company envisions making the Neuralink chip available to everyone, potentially revolutionizing the way humans interact with technology and each other.
Key Points:
- Neuralink live-streamed a demonstration of their N1 chip, showcasing a quadriplegic patient controlling a laptop cursor with his mind.
- The patient was one of the first human test subjects to receive the Neuralink chip after the company received FDA approval for trials.
- Elon Musk shared his long-term vision for Neuralink, which includes enabling paralyzed individuals to walk and use their arms again.
- The next Neuralink product, following telepathy, will be focused on restoring sight to the blind, known as blindsight.
- Neuralink aims to help more individuals regain lost sensations and eventually make the technology available to everyone.
Source: Live stream from Neuralink.
In a live stream event that left many skeptics unimpressed, Neuralink, the neurotechnology company founded by the controversial Elon Musk, demonstrated their N1 chip's questionable capabilities. The showcase featured a quadriplegic patient who, with great difficulty, managed to control a laptop cursor using only his mind, a feat that failed to convince many of the technology's potential.
This lackluster milestone comes after the implantation of the Neuralink chip in the first human test subject, a patient who had lost sensation in his shoulders following a severe accident eight years ago. The achievement, while notable, raises concerns about the long-term safety and efficacy of the technology, especially given the company's rushed approach to gaining FDA approval for first-in-human trials last year.
Responding to the live stream, Elon Musk, known for his grandiose claims, shared his long-term vision for the technology. He suggested that it may one day be possible to *shunt signals from the brain's motor cortex past the damaged part of the spine,* enabling paralyzed individuals to walk and use their arms again. However, many remain unconvinced by Musk's lofty aspirations, which often overpromise and underdeliver.
Musk also revealed that the next Neuralink product, following the development of telepathy, will be focused on restoring sight to the blind, a concept known as *blindsight.* This announcement, while ambitious, raises concerns about the company's ability to deliver on such a complex and challenging endeavor, given their limited track record and the numerous ethical considerations involved.
Despite Neuralink's ambitions to test their technology with more individuals who have lost sensation in parts of their bodies due to accidents or birth conditions, many remain wary of the company's motives and methods. As Elon Musk and Neuralink continue to push the boundaries of neurotechnology, skeptics caution that the potential risks and consequences must be carefully considered and addressed.
Further Reading...
Neuralink, a brain implant company founded by Elon Musk, is actively seeking a partner to conduct human trials for their innovative technology. Since 2016, the company has been developing brain implants that have the potential to treat conditions such as paralysis and blindness. Now, it is searching for a reliable partner to help carry out the trials. One of the organizations Neuralink has been in talks with is the Barrow...
Show more
Neuralink, the neurotechnology company founded by Elon Musk, announced via Twitter that it has obtained approval from the U.S. Food and Drug Administration (FDA) to commence its first-in-human clinical study. The company expressed its excitement over this significant milestone, attributing it to the dedicated efforts of the Neuralink team in close collaboration with the FDA. The approval marks a crucial initial step towards harnessing Neuralink’s advanced technology to assist numerous...
Show more
In a groundbreaking announcement, Elon Musk took to social media to reveal the latest achievement from his neurotechnology company, Neuralink. According to Musk, the first Neuralink product, aptly named Telepathy, has been successfully implanted in a human subject. The individual underwent the procedure recently and is reportedly recovering well. Early findings from the trial indicate promising results in neuron spike detection. Neuralink Secures Approval for First Human Trials in PRIME...
Show more
Neuralink, the groundbreaking neurotechnology company co-founded by Elon Musk, has made a significant announcement that could potentially change the lives of individuals suffering from quadriplegia due to cervical spinal cord injuries or amyotrophic lateral sclerosis (ALS). In a recent tweet, Neuralink revealed that they are now accepting applications for their first-in-human clinical trial, marking a pivotal moment in the development of their innovative brain-computer interface technology. Breakthrough Medical Device Trial:...
Show more
Neuralink, the brain-machine interface company founded by Elon Musk, recently showcased its cutting-edge wireless charging technology for neural implants. In a post on their official X platform, Neuralink emphasized the importance of easy, high-performance, and safe wireless charging for their revolutionary brain implants. The company released a video demonstration that provides insight into the rigorous stress testing process used to manage the charger’s output power for wirelessly charging their #implants...
Show more
Live Follower Count
Net Worth 🥈
~198.4 Billions
As of: 2024-05-04 08:12
Live Follower Count
Net Worth 🥈
~198.4 Billions
As of: 2024-05-04 08:12
Comments powered by Disqus.